Gastric Cancer Market by Disease Type (Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, and Others), Treatment Type (Immunotherapy, Targeted Therapy, Chemotherapy, and Radiation Therapy and Surgery), Drug Class Outlook (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, and Others), Route of Administration (Oral and Injectable), Distribution Channel (Hospital Pharmacies, Specialty & Retail Pharmacies, and Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2031

  Reports Overview      Table of Content